on Moderna, Inc. (NASDAQ:MRNA)
Moderna to Present Extensive Research on Infectious Diseases
Moderna, Inc. (NASDAQ:MRNA) is set to present its latest research on various infectious diseases at the ESCMID Global Congress, held in Vienna from April 11-15, 2025. The focus will be on diseases such as COVID-19, influenza, RSV, CMV, norovirus, and mpox, showcasing the company's broad research efforts.
The event will include twelve presentations from Moderna, comprising three oral presentations and nine poster/e-poster presentations. Highlights include advancements in COVID-19 vaccine efficacy, RSV vaccine immunogenicity, and interim results from a novel mpox vaccine trial.
Presentations will cover topics from long-term vaccine safety to the immunogenicity of various mRNA-based vaccines, emphasizing Moderna's innovative approach to mRNA technology for disease prevention.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Moderna, Inc. news